Mohamed Eid, MD, MSc, MHA, is a seasoned leader in biopharma with extensive experience in clinical development and medical affairs. They served as Chief Medical Officer at Novo Nordisk from 2011 to 2015 and have held significant roles at Boehringer Ingelheim and Bristol-Myers Squibb, including their current position as Chief Medical Officer at Verdiva Bio since 2024. Mohamed's educational background includes multiple master's degrees and executive leadership training from prestigious institutions such as Harvard Business School and the University of Oxford. They continue to advance their expertise in healthcare delivery and leadership.
This person is not in the org chart
This person is not in any teams
This person is not in any offices